Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells

Immunobiology

Volumn 214, Issue 5, 2009, Pages 342-349

  Wang, Feng ^a   Wan, Lagen ^a   Zhang, Caicheng ^a   Zheng, Xiaofeng ^a   Li, Junming ^a   Chen, Zhonghua Klaus ^b  

^a NANCHANG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Galectin 9; Immunosuppressive; Skin graft; Tregs

Indexed keywords

CD4 ANTIGEN; CYTOKINE; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MEMBRANE PROTEIN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; GRAFT SURVIVAL; IMMUNE DEFICIENCY; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLOGRAFT; TH1 CELL; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BLOCKING; GALECTINS; GRAFT REJECTION; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRANSPLANTATION IMMUNOLOGY;

EID: 64049088217     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.10.007     Document Type: Article

References (27)

1. Anderson A.C., and Anderson D.E. TIM-3 in autoimmunity. Curr. Opin. Immunol. 18 (2006) 665-669
2. + T cells regulate the expansion of CD4 T cells through the production of IL-10. J. Immunol. 166 (2001) 3008-3017
3. + regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
4. Bluestone J.A., and Abbas A.K. Natural versus adaptative regulatory T cells. Nat. Immunol. 3 (2003) 253-257
5. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., and McClanahan T. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116 (2006) 1317-1326
6. Khademi M., Illes Z., Gielen A.W., Marta M., Takazawa N., Allan C.B., Brundin L., and Hannerz J. T cell Ig- and mucin-domaincontaining molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human TH1 and TH2 cells and in cerebrospinal fluidderived mononuclear cells in multiple sclerosis. J. Immunol. 172 (2004) 7169-7176
7. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., and Strober W. Transforming growth factor (TGF)-β1-producing regulatory T cells induce smadmediated interleukin-10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J. Exp. Med. 198 (2003) 1179-1188
8. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., and Sedgwick J.D. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
9. + regulatory T cells. J. Immunol. 175 (2005) 4180-4183
10. Liu Y., Ng Y., and Lillehei K.O. Cell mediated immunotherapy: a new approach to the treatment of malignant glioma. Cancer Control. 10 (2003) 138-147
11. + T(R) cells suppress innate immune pathology through cytokine dependent mechanisms. J. Exp. Med. 197 (2003) 111-119
12. + Foxp3+ regulatory T cells. Transplant. Immunol. 19 (2008) 127-135
13. + T cells with PD-1-dependent regulatory activities. Immunology 120 (2006) 73-82
14. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., and Greenfield E.A. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 (2002) 536-541
15. Sakaguchi S. Regulatory T cells: mediating compromises between host and parasite. Nat. Immunol. 4 (2003) 10-11
16. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
17. + regulatory T cell function in alloimmunity. J. Immunol. 176 (2006) 329-334
18. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
19. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 (2002) 135-142
20. Sylvia F.K., Jennifer F.N., Sarah E.D., Masheka A.B., Gatewood S.J.L., Dolores B.N., Daniela C., Ellen K.S., Noel R.R., and DeLisa F. Cutting edge: T Cell Ig Mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J. Immunol. 176 (2006) 6411-6415
21. + regulatory T cells. Hum. Immunol. 66 (2005) 222-230
22. + regulatory T cells. J. Leukoc. Biol. 80 (2006) 458-470
23. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338-344
24. + regulatory T cells and their ligands: implication for immunotherapy. Immunity 20 (2004) 107-118
25. + alloreactive T cell and prolongs survival of skin graft. Cell. Immunol. 250 (2007) 68-74
26. Wang F., He W.T., Yuan J., Wu K., Zhou H.M., Zhang W.N., and Chen Z.K. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transplant. Immunol. 19 (2008) 12-19
27. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., and Strom T.B. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6 (2005) 1245-1252